Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
Status:
Not yet recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of OMA102 1 mg and
OMA102 2 mg versus placebo in the treatment of female pattern hair loss.